Karol Sikora

Dr. Karol Sikora

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
PSPaulina Szymczak
Paulina Szymczak
MMMarcin Możejko
Marcin Możejko
TGTomasz Grzegorzek
Tomasz Grzegorzek
RJRadosław Jurczak
Radosław Jurczak
MBMarta Bauer
Marta Bauer
ESEwa Szczurek
Ewa Szczurek
Antimicrobial peptides emerge as compounds that can alleviate the global health hazard of antimicrobial resistance, prompting a need for novel computational approaches to peptide generation. Here, we propose HydrAMP, a conditional variational autoencoder that learns lower-dimensional, continuous representation of peptides and captures their antimicrobial properties. The model disentangles the learnt representation of a peptide from its antimicrobial conditions and leverages parameter-controlled creativity. HydrAMP is the first model that is directly optimized for diverse tasks, including unconstrained and analogue generation and outperforms other approaches in these tasks. An additional preselection procedure based on ranking of generated peptides and molecular dynamics simulations increases experimental validation rate. Wet-lab experiments on five bacterial strains confirm high activity of nine peptides generated as analogues of clinically relevant prototypes, as well as six analogues of an inactive peptide. HydrAMP enables generation of diverse and potent peptides, making a step towards resolving the antimicrobial resistance crisis.

3 December 2020 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
KSKarol Sikora
Karol Sikora
MJMaciej Jaśkiewicz
Maciej Jaśkiewicz
DNDamian Neubauer
Damian Neubauer
DMDorian Migoń
Dorian Migoń
Wojciech Kamysz, Pharm. D.Wojciech Kamysz, Pharm. D.
Wojciech Kamysz, Pharm. D.
Peptides and proteins constitute a large group of molecules that play multiple functions in living organisms. In conjunction with their important role in biological processes and advances in chemical approaches of synthesis, the interest in peptide-based drugs is still growing. As the side chains of amino acids can be basic, acidic, or neutral, the peptide drugs often occur in the form of salts with different counter-ions. This review focuses on the role of counter-ions in peptides. To date, over 60 peptide-based drugs have been approved by the FDA. Based on their area of application, biological activity, and results of preliminary tests they are characterized by different counter-ions. Moreover, the impact of counter-ions on structure, physicochemical properties, and drug formulation is analyzed. Additionally, the application of salts as mobile phase additives in chromatographic analyses and analytical techniques is highlighted.

6 January 2018 in Amino Acids
Verified
Journal Article
Open access
PDF file
KSKarol Sikora
Karol Sikora
MJMaciej Jaśkiewicz
Maciej Jaśkiewicz
DNDamian Neubauer
Damian Neubauer
MBMarta Bauer
Marta Bauer
SBSylwia Bartoszewska
Sylwia Bartoszewska
Wojciech Kamysz, Pharm. D.Wojciech Kamysz, Pharm. D.
Wojciech Kamysz, Pharm. D.
In view of an appreciable increase in resistance of Staphylococcus aureus to the conventional antibiotics, it is desired to develop new effective drugs. Antimicrobial peptides (AMPs) seem to be attractive candidates. In general, AMPs samples used for in vitro studies consist of a peptide, counter-ion, and water. The presence of the counter-ion could be significant as it affects peptide secondary structure and biological activity. The purpose of this study was to estimate the impact of counter-ion on antistaphylococcal activity of selected AMPs (CAMEL, citropin 1.1, LL-37, pexiganan, temporin A). To do this, three kinds of salts were prepared, namely, acetates, hydrochlorides, and trifluoroacetates. In addition, the hemolytic activity against human red blood cells (hRBCs) and cytotoxicity (HaCaT) were determined. The results indicate that there is a substantial difference between different salts, but the pattern is not consistent for the peptides. In general, the antistaphylococcal activity decreased in the order: CAMEL > temporin A > pexiganan > citropin 1.1 ≫ LL-37. The highest selectivity indexes were determined for CAMEL hydrochloride, pexiganan acetate, and temporin A trifluoroacetate. This study shows how important is to take into account the kind of counter-ions when designing novel peptide-based antimicrobials.

1 October 2011 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
BDBarbara Dmochowska
Barbara Dmochowska
Jacek PiosikJacek Piosik
Jacek Piosik
AWAnna Woziwodzka
Anna Woziwodzka
KSKarol Sikora
Karol Sikora
AWAndrzej Wiśniewski
Andrzej Wiśniewski
Grzegorz WęgrzynGrzegorz Węgrzyn
Grzegorz Węgrzyn

12 July 2017 in International Journal of Peptide Research and Therapeutics
Verified
Journal Article
Open access
PDF file
KSKarol Sikora
Karol Sikora
DNDamian Neubauer
Damian Neubauer
MJMaciej Jaśkiewicz
Maciej Jaśkiewicz
Wojciech Kamysz, Pharm. D.Wojciech Kamysz, Pharm. D.
Wojciech Kamysz, Pharm. D.
In view of the increasing interest in peptides in various market sectors, a stronger emphasis on topics related to their production has been seen. Fmoc-based solid phase peptide synthesis, although being fast and efficient, provides final products with significant amounts of trifluoroacetate ions in the form of either a counter-ion or an unbound impurity. Because of the proven toxicity towards cells and peptide activity inhibition, ion exchange to more biocompatible one is purposeful. Additionally, as most of the currently used counter-ion exchange techniques are time-consuming and burdened by peptide yield reduction risk, development of a new approach is still a sensible solution. In this study, we examined the potential of peptide counter-ion exchange using non-aqueous organic solvents saturated with HCl. Counter-ion exchange of a model peptide, citropin 1.1 (GLFDVIKKVASVIGGL-NH2), for each solvent was conducted through incubation with subsequent evaporation under reduced pressure, dissolution in water and lyophilization. Each exchange was performed four times and compared to a reference method—lyophilization of the peptide from an 0.1 M HCl solution. The results showed superior counter-ion exchange efficiency for most of the organic solutions in relation to the reference method. Moreover, HCl-saturated acetonitrile and tert-butanol provided a satisfying exchange level after just one repetition. Thus, those two organic solvents can be potentially introduced into routine peptide counter-ion exchange.

Verified
Journal Article
Open access
PDF file
DNDamian Neubauer
Damian Neubauer
MJMaciej Jaśkiewicz
Maciej Jaśkiewicz
MBMarta Bauer
Marta Bauer
AOAgata Olejniczak-Kęder
Agata Olejniczak-Kęder
ESEmilia Sikorska
Emilia Sikorska
Wojciech Kamysz, Pharm. D.Wojciech Kamysz, Pharm. D.
Wojciech Kamysz, Pharm. D.
Ultrashort cationic lipopeptides (USCLs) and gemini cationic surfactants are classes of potent antimicrobials. Our recent study has shown that the branching and shortening of the fatty acids chains with the simultaneous addition of a hydrophobic N-terminal amino acid in USCLs result in compounds with enhanced selectivity. Here, this approach was introduced into arginine-rich gemini cationic surfactants. l-cystine diamide and l-lysine amide linkers were used as spacers. Antimicrobial activity against planktonic and biofilm cultures of ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.) strains and Candida sp. as well as hemolytic and cytotoxic activities were examined. Moreover, antimicrobial activity in the presence of human serum and the ability to form micelles were evaluated. Membrane permeabilization study, serum stability assay, and molecular dynamics were performed. Generally, critical aggregation concentration was linearly correlated with hydrophobicity. Gemini surfactants were more active than the parent USCLs, and they turned out to be selective antimicrobial agents with relatively low hemolytic and cytotoxic activities. Geminis with the l-cystine diamide spacer seem to be less cytotoxic than their l-lysine amide counterparts, but they exhibited lower antibiofilm and antimicrobial activities in serum. In some cases, geminis with branched fatty acid chains and N-terminal hydrophobic amino acid resides exhibited enhanced selectivity to pathogens over human cells.